U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07246681) titled 'Lignin in Treatment of Helicobacter Pylori Infection' on Nov. 17.
Brief Summary: The goal of this clinical trial is to learn if drug hydrolyzed lignin works to treat H pylori infection in adults. It will also learn about the safety of drug lignin n the sitting of H pylori infection, and if it halts the side effects associated with H pylori triple therapy. The main questions it aims to answer are:
* Does drug hydrolyzed lignin improve the H pylori eradiation rate when it is added to the standard triple therapy used in treatment of H pylori?
* What medical problems do participants experience when taking drug hydrolyzed lignin? Resea...